TWP
PDSB icon

Tempus Wealth Planning’s PDS Biotechnology PDSB Stock Holding History

Tempus Wealth Planning’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.5K Hold
61,800
– – 0.01% 281
2026
Q1 		$37.4K Hold
61,800
– – 0.01% 270
2025
Q4 		$47.6K Buy
61,800
+14,000
+29% +$12.6K 0.01% 274
2025
Q3 		$48.3K Hold
47,800
– – 0.01% 275
2025
Q2 		$63.6K Buy
47,800
+29,000
+154% +$39.4K 0.02% 259
2025
Q1 		$22.4K Hold
18,800
– – 0.01% 252
2024
Q4 		$30.6K Hold
18,800
– – 0.01% 246
2024
Q3 		$71.8K Hold
18,800
– – 0.03% 219
2024
Q2 		$55.1K Buy
+18,800
New +$60.2K 0.02% 205

Other funds holding PDSB

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Tempus Wealth Planning's PDSB Position: Q2 2026 in Review

Tempus Wealth Planning held its PDS Biotechnology (PDSB) position steady in Q2 2026 at 61,800 shares worth $54.5K. The position accounts for 0.01% of the portfolio, ranked #281.

Tempus Wealth Planning first reported a position in PDSB in Q2 2024 and has held it in 9 quarters since. The position peaked at $71.8K in Q3 2024. 52 funds tracked by Wall St. Rank hold PDSB as of Q2 2026.

  • Tempus Wealth Planning held 61,800 shares of PDS Biotechnology worth $54.5K as of Q2 2026.
  • Tempus Wealth Planning left its PDS Biotechnology share count unchanged in Q2 2026.
  • PDS Biotechnology made up 0.01% of Tempus Wealth Planning's portfolio in Q2 2026, its #281 holding.
  • Tempus Wealth Planning first reported a position in PDS Biotechnology in Q2 2024 and has held it in 9 quarters since.
  • Tempus Wealth Planning's PDS Biotechnology position peaked at $71.8K in Q3 2024.
  • 52 funds tracked by Wall St. Rank held PDS Biotechnology as of Q2 2026.

Based on Tempus Wealth Planning's 13F filing for Q2 2026, filed 22 Jul 2026.